Literature DB >> 1486292

Conditioning regimens for allogeneic bone marrow transplantation.

E A Copelan1.   

Abstract

Conditioning regimens for transplantation are important in determining transplant outcome. This review focuses on transplantation in aplastic anemia and leukemia using marrow from HLA-identical siblings. Results of conditioning with newer regimens such as busulfan plus cyclophosphamide and etoposide plus total body irradiation are reviewed and compared to results achieved with cyclophosphamide and total body irradiation. The potential for improved results using recent innovations such as dose adjustment of busulfan, agents which may decrease transplant-related toxicity, and directed radiation are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1486292     DOI: 10.1016/0268-960x(92)90019-m

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  4 in total

1.  Simultaneous occurrence of osteosarcoma and osteochondroma following treatment of neuroblastoma with chemotherapy, radiotherapy, and bone marrow transplantation.

Authors:  M Poustchi-Amin; J C Leonidas; S S Elkowitz
Journal:  Pediatr Radiol       Date:  1996

Review 2.  Space-time considerations for hematopoietic stem cell transplantation.

Authors:  Deepta Bhattacharya; Lauren I Richie Ehrlich; Irving L Weissman
Journal:  Eur J Immunol       Date:  2008-08       Impact factor: 5.532

3.  Airborne cytotoxicity in the DiSC assay caused by solutions of treosulfan but not busulphan.

Authors:  A G Bosanquet; A R Burlton
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

Review 4.  Total Body Irradiation in Haematopoietic Stem Cell Transplantation for Paediatric Acute Lymphoblastic Leukaemia: Review of the Literature and Future Directions.

Authors:  Bianca A W Hoeben; Jeffrey Y C Wong; Lotte S Fog; Christoph Losert; Andrea R Filippi; Søren M Bentzen; Adriana Balduzzi; Lena Specht
Journal:  Front Pediatr       Date:  2021-12-03       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.